|In response to a query this evening from the Singapore Exchange Securities Trading Limited (the SGX-ST) regarding a substantial increase in the price of the shares of TalkMed Group Limited (TGL/the Company), the Company would like to respond as follows:-
Question 1: Are you aware of any information not previously announced concerning you (the issuer), your subsidiaries or associated companies which, if known, might explain the trading? – If yes, the information must be announced immediately.
TGLs Response: The Company is not aware of any information not previously announced concerning the Company or its subsidiaries or associated companies that might explain the substantial increase in the price of the shares of TGL.
Question 2: Are you aware of any other possible explanation for the trading?
TGLs Response: The Company is not aware of any other possible explanation for the trading.
Question 3: Can you confirm your compliance with the listing rules and, in particular, listing rule 703?
TGLs Response: The Company confirms that it is in compliance with the Catalist Rules, in particular, Rule 703.
On behalf of the Board
Quek Hiong How
Chief Financial Officer
11 February 2014
The Announcement has been prepared by the Company and its contents have been reviewed by the Companys sponsor, Hong Leong Finance Limited (the Sponsor), for compliance with the relevant rules of the SGX-ST. The Sponsor has not independently verified the contents of the Announcement.
The Announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of the Announcement, including the correctness of any of the statements or opinions made or reports contained in the Announcement.
The contact person for the Sponsor is Ms. Joan Ling, Senior Vice President, Head of Corporate Finance, at 16 Raffles Quay #40-01A Hong Leong Building, Singapore 048581, Telephone: (65) 6415-9886.